-
Results of this small double-blind RCT suggest that neither magnetic nor copper bracelets have a place in the treatment of osteoarthritis.
-
This RCT compared acupuncture to venlafaxine for management of hot flashes in breast cancer patients. Both acupuncture and venlafaxine were given for 12 weeks, and then the subjects were followed. Both groups had improvements in their symptoms, but the venlafaxine group had side effects, and the acupuncture group did not.
-
Thrombocytopenia is a well-established adverse effect of many conventional drugs. This systematic review found few reports of such adverse effects associated with complementary and alternative medicines, herbal remedies, nutritional supplements, foods, and beverages.
-
This engaging epidemiologic survey assessed microbial contamination of soda-fountain drinks, dispensed from nine different fountain machines, relative to current U.S. drinking water standards.
-
In the evening after work, and in a generally relaxed environment, subjects had their coronary flow velocities in the left anterior descending artery recorded by non-invasive transthoracic Doppler echocardiography, and coronary flow velocity reserve (CFVR) was calculated. CFVR was assessed at baseline and immediately following 30 minutes of lavender aromatherapy, as were serum cortisol levels.
-
Reflexology is an ancient therapy that has become popular in some health care settings. Its use with cancer patients arises from its reputation for reducing pain, relieving anxiety, and promoting relaxation.
-
The second part of this series reviews specific features of dietary intake that can influence fertility as well as overall general medical health.
-
Irritable Bowel Syndrome (IBS) is a chronic gastrointestinal (GI) illness that is defined by symptoms of bloating, lower abdominal pain, and abnormal defecation patterns after evaluation excludes colitis or structural abnormalities as the cause.
-
Goal: To assess the effect of Tai Chi Chuan (TCC) training on risk factors for coronary artery disease (CAD) in people with dyslipidemia.
-
Enrollment into the Trial to Assess Chelation Therapy (TACT), a five-year, $30-million National Institutes of Health-funded clinical study, has been stopped, according to Heartwire, a professional news service of WebMD.